1 :

1100:

Client reports muscle weakness and tingling in their hands and face. Client is alert to person, place, time, and situation. Speech clear. Heart rate irregular. Radial pulse +3 bilateral. Respirations even and nonlabored. Scattered rhonchi posterior bases. Abdomen rounded and nondistended. Bowel sounds hyperactive in all 4 quadrants. Skin warm dry and intact. Capillary refill less than 2 seconds. Turgor elastic. No edema present.

1115: 

A Labs, vital signs, and ECG were obtained. Urinalysis collection is pending. Client is being transferred to the medical-surgical unit.

1100:

Temperature 36.4° C (97.5° F)

Heart rate 58/min

Respiratory rate 20/min

Blood pressure 98/64 mm Hg

Oxygen saturation 97% on room air

1115:

Temperature 36.4° C (97.5° F)

Heart rate 64/min

Respiratory rate 22/min

Blood pressure 104/70mm Hg

Oxygen saturation 96% on room air

1130:

Sodium 140 mEq/L (136 to 145 mEq/L)

Potassium 6 mEq/L (3.5 to 5 mEq/L)

BUN 18 mg/dL (10 to 20 mg/dL)

Creatinine 0.8 mg/dL (0.5 to 1 mg/dL)

Hgb 14 g/dL (12 to 16 g/dL)

Hct 45% (37% to 47%)

1130:

ECG: Peaked T waves with absent P waves. Rate is 58/min.


For each potential provider prescription, click to specify if the prescription is appropriate or inappropriate for the client. There must be at least 1 selection in every row. There does not need to be a selection in every column.


Provider Prescription appropriate inappropriate
Administer hydralazine IV.
Administer sodium polystyrene rectally.
Administer insulin IV.
Administer calcium gluconate IV.
Administer potassium chloride IV.

Hint : 🔶Stabilize the heart, then lower potassium.

Correct Answers

  • Administer hydralazine IV. [ inappropriate ]
  • Administer sodium polystyrene rectally. [ appropriate ]
  • Administer insulin IV. [ appropriate ]
  • Administer calcium gluconate IV. [ appropriate ]
  • Administer potassium chloride IV. [ inappropriate ]

Rationale :

Appropriate

Administer sodium polystyrene rectally

🔶Sodium polystyrene sulfonate lowers serum potassium by exchanging sodium for potassium within the gastrointestinal tract.

🔶The bound potassium is then removed from the body through stool, producing an actual reduction in total-body potassium.

🔶Rectal administration can be used when oral administration is not appropriate or when the client cannot safely take the medication by mouth.

🔶Its effect is relatively slow, so it should not be relied upon as the only treatment when hyperkalemia has already produced ECG abnormalities.

🔶It is appropriate as an adjunct to faster therapies while the nurse monitors bowel function, potassium levels, and signs of intestinal complications.

Administer insulin IV

🔶 Intravenous regular insulin rapidly shifts potassium from the extracellular fluid into the body’s cells.

🔶Insulin stimulates the sodium-potassium pump, lowering the serum potassium concentration without immediately removing potassium from the body.

🔶This intervention is appropriate because the client has both an elevated potassium level and dangerous ECG manifestations.

🔶IV dextrose is commonly administered with insulin unless the client is significantly hyperglycemic, because insulin can cause severe hypoglycemia.

🔶The nurse should monitor blood glucose frequently and reassess the potassium level and cardiac rhythm after treatment.

Administer calcium gluconate IV

🔶Intravenous calcium gluconate stabilizes the cardiac cell membrane and reduces the risk of ventricular dysrhythmias caused by hyperkalemia.

🔶It is especially indicated when ECG changes such as peaked T waves, absent P waves, bradycardia, or QRS widening are present.

🔶Calcium gluconate acts rapidly but does not lower the serum potassium concentration or remove potassium from the body.

🔶Potassium-lowering treatments such as insulin with dextrose must therefore be administered in addition to calcium.

🔶The nurse should maintain continuous ECG monitoring and administer the medication slowly through a patent IV line according to the prescribed rate.

Inappropriate

Administer hydralazine IV

🔶 Hydralazine is an antihypertensive vasodilator that lowers blood pressure and does not treat hyperkalemia or its cardiac effects.

🔶The client’s blood pressure is already low-normal at 98/64 mm Hg, so hydralazine could cause dangerous hypotension.

Administer potassium chloride IV

🔶Potassium chloride would further increase the client’s already elevated serum potassium and worsen the risk of lethal cardiac dysrhythmias.

🔶Potassium-containing medications and fluids should be withheld while emergency measures are used to stabilize the heart and reduce potassium.


Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

2 :

0620:

Client admitted to the ED with reports of crushing chest pain, shortness of breath, and nausea and vomiting. Client reports symptoms began approximately 45 minutes ago while eating breakfast. 12-lead ECG performed and shows ST-segment elevation in 4 leads.

0630:

Two 18-gauge IV catheters inserted into right and left forearm.

0623:

Blood pressure 138/78 mm Hg

Heart rate 98/min

Respiratory rate 18/min

Temperature 37.2° C (99°F)

Oxygen saturation 95% on room air

0640:

Blood pressure 136/80 mm Hg

Heart rate 96/min

Respiratory rate 20/min

Temperature 37.2° C (99° F)

Oxygen saturation 96% on room air

0625:

Troponin 0.67 ng/mL (less than 0.03 ng/mL)


Which of the following medications would the nurse expect the physician to prescribe for this client? Select All That Apply.


Answer Options

Hint : ❤️Prevent clot growth and relieve ischemic pain.

Correct Answers:

  • Morphine
  • Aspirin
  • Heparin


Rationale :

Morphine

💊 Morphine may be prescribed for severe, persistent ischemic chest pain that is not relieved by first-line treatment such as nitroglycerin.

💊 It reduces pain and anxiety while producing venodilation, which can decrease venous return and myocardial oxygen demand.

💊 The medication should be administered cautiously because it can cause hypotension, respiratory depression, sedation, and bradycardia.

💊 The nurse should monitor blood pressure, respiratory status, level of consciousness, and pain response closely after administration.

💊 Morphine is not routinely given to every STEMI client, but it is appropriate when significant chest pain continues despite initial anti-ischemic therapy.

Aspirin

🩸 Aspirin should be administered promptly to a client with a suspected acute myocardial infarction unless a contraindication exists.

🩸 It irreversibly inhibits platelet aggregation and helps prevent the coronary thrombus from enlarging.

🩸 The client is usually instructed to chew non-enteric-coated aspirin because chewing promotes faster absorption and a more rapid antiplatelet effect.

🩸 Early aspirin administration reduces recurrent myocardial infarction, vascular complications, and mortality.

🩸 The nurse should assess for active bleeding, severe aspirin allergy, and other contraindications before administering it.

Heparin

🛡️ Heparin is an anticoagulant used during acute coronary syndrome to prevent further formation and extension of the coronary thrombus.

🛡️ It does not dissolve the existing clot but inhibits clotting factors and reduces the risk of additional coronary artery occlusion.

🛡️ Heparin is commonly administered when the client is being prepared for percutaneous coronary intervention or receiving other reperfusion therapy.

🛡️ The nurse should monitor for bleeding, thrombocytopenia, hematuria, gastrointestinal bleeding, and changes in prescribed coagulation studies.

🛡️ Its use supports coronary reperfusion treatment and helps reduce recurrent ischemic events during the acute phase of STEMI care.


Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

3 :

Today, 0830:

Client presents to the clinic for the management of hypertension and review of laboratory tests obtained 3 days before this visit. Client has a history of hypertension and asthma. Client is currently taking lisinopril 5 mg PO daily.

Today, 0845:

Client is alert and oriented to person, place, time, and situation. Respirations are even and nonlabored. Scattered wheezes auscultated in bilateral anterior lung fields. Vital signs were obtained.

Today, 0900:

Provider in to examine client. A new prescription has been received. Nurse to provide education to the client about new prescription.

Today, 0845:

Temperature 37.1°C (98.8° F)

Heart rate 90/min

Respiratory Rate 20/min

Blood pressure 150/70 mm Hg

Oxygen saturation 95%

3 days ago:

Hemoglobin 11 g/dL (12 to 16 g/dL)

Hematocrit 46% (37% to 47%)

Sodium 130 mEq/L (136 to 145 mEq/L)

Potassium 5.6 mEq/L (3.5 to 5 mEq/L)

BUN 30 mg/dL (10 to 20 mg/dL)

Creatine 3 mg/dL (0.5 to 1 mg/dL)

Today, 0900:

Spironolactone 25 mg PO twice daily


Click to highlight the client's findings that are a potential contraindication to the client's new prescription and the nurse should report to the provider. To deselect a finding, click on the finding again.


Nurses' Notes Today, 0830: Client presents to the clinic for the management of hypertension and review of laboratory tests obtained 3 days before this visit. Client has a history of hypertension and asthma. Client is currently taking lisinopril 5 mg PO daily. Today, 0845: Client is alert and oriented to person, place, time, and situation. Respirations are even and nonlabored. Scattered wheezes auscultated in bilateral anterior lung fields. Vital signs were obtained. Today, 0900: Provider in to examine client. A new prescription has been received. Nurse to provide education to the client about new prescription. Vital Signs Today, 0845: Temperature 37.1°C (98.8° F) Heart rate 90/min Respiratory Rate 20/min Blood pressure 150/70 mm Hg Oxygen saturation 95% Laboratory Results 3 days ago: Hemoglobin 11 g/dL (12 to 16 g/dL) Hematocrit 46% (37% to 47%) Sodium 130 mEq/L (136 to 145 mEq/L) Potassium 5.6 mEq/L (3.5 to 5 mEq/L) BUN 30 mg/dL (10 to 20 mg/dL) Creatine 3 mg/dL (0.5 to 1 mg/dL)

Hint : 💊Identify potassium retention and renal impairment.

Correct Highlights :
  • Client is currently taking lisinopril 5 mg PO daily.
  • Sodium 130 mEq/L (136 to 145 mEq/L)
  • Potassium 5.6 mEq/L (3.5 to 5 mEq/L)
  • BUN 30 mg/dL (10 to 20 mg/dL)
  • Creatine 3 mg/dL (0.5 to 1 mg/dL)

Rationale :

The client is currently taking lisinopril 5 mg PO daily

🩺 Lisinopril is an ACE inhibitor that reduces aldosterone secretion and can increase the serum potassium level.

🩺 Spironolactone is a potassium-sparing diuretic that also blocks aldosterone and promotes potassium retention.

🩺 Administering these medications together significantly increases the client’s risk for severe hyperkalemia.

🩺 This interaction is especially dangerous because the client already has elevated potassium and impaired renal function.

🩺 The nurse should report the concurrent lisinopril therapy before administering the newly prescribed spironolactone.

Sodium 130 mEq/L

🩺 A sodium level of 130 mEq/L indicates hyponatremia, which can be worsened by diuretic therapy.

🩺 Spironolactone promotes sodium and water excretion while retaining potassium.

🩺 Further sodium loss can increase the risk for weakness, confusion, headache, seizures, and other neurological complications.

🩺 The sodium imbalance should be evaluated before spironolactone is initiated, particularly in a client with renal impairment.

🩺 The nurse should report this abnormal laboratory result so the provider can determine whether the medication is safe.

Potassium 5.6 mEq/L

🩺 A potassium level of 5.6 mEq/L indicates hyperkalemia, which is a major contraindication to spironolactone therapy.

🩺 Spironolactone blocks aldosterone and decreases renal potassium excretion, causing additional potassium retention.

🩺 Further elevation can produce muscle weakness, paresthesia, conduction abnormalities, life-threatening dysrhythmias, and cardiac arrest.

🩺 The risk is increased because the client is also taking lisinopril, which can elevate potassium.

🩺 The nurse should withhold the medication and immediately report the elevated potassium level to the provider.

BUN 30 mg/dL

🩺 A BUN level of 30 mg/dL is elevated and suggests decreased renal clearance, dehydration, or another form of renal dysfunction.

🩺 Spironolactone depends on adequate kidney function for safe elimination and electrolyte regulation.

🩺 Impaired renal function increases the risk that potassium will accumulate to dangerous levels.

🩺 The elevated BUN is especially concerning when considered with the client’s markedly elevated creatinine level.

🩺 The nurse should report this result before administering spironolactone so renal function can be further evaluated.

Creatinine 3 mg/dL

🩺 A creatinine level of 3 mg/dL indicates significant renal impairment.

🩺 Clients with severely reduced kidney function cannot excrete potassium effectively, increasing the risk for spironolactone-induced hyperkalemia.

🩺 Spironolactone is generally avoided or used with extreme caution in clients with substantial renal dysfunction.

🩺 The combination of renal impairment, existing hyperkalemia, and concurrent lisinopril therapy creates a high risk for a life-threatening electrolyte disturbance.

🩺 The nurse should report the elevated creatinine and clarify the prescription before administering the medication.


Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

4 :

1400:

Client is admitted for the management of deep vein thrombosis of their lower extremity. Client has received IV anticoagulant therapy.

1600:

Client is scheduled for discharge. Will provide education to the client about the self- administration of medication.

1400:

Discharge to home. Enoxaparin 40 mg subcut twice daily for 2 weeks. Use prefilled syringes. Client to self-administer. Nursing to provide education to client about self-administration of medication before discharge.


Select the 3 statements the nurse should make.


Answer Options

Hint : 💉Inject subcutaneously without rubbing the site.

Correct Answers:

  • "Rotate Injection sites."
  • "Inject the medication at a 90-degree angle."
  • "Pinch up a skin area before Injection."


Rationale :

“Rotate injection sites.”

💉 Rotating injection sites helps prevent repeated trauma to the same area of subcutaneous tissue.

💉 Enoxaparin is commonly administered into the left or right anterolateral or posterolateral abdominal wall, at least 5 cm or 2 inches from the umbilicus.

💉 The client should alternate sides and avoid injecting into bruised, scarred, tender, hardened, or inflamed areas.

💉 Site rotation decreases the risk of bruising, hematoma formation, tissue irritation, and poor medication absorption.

💉 The nurse should instruct the client to keep a simple record of injection locations to ensure consistent rotation.

“Inject the medication at a 90-degree angle.”

💉 Enoxaparin is administered into the subcutaneous tissue, and a 90-degree angle is appropriate when a skinfold is pinched.

💉 The needle should be inserted completely into the skinfold to ensure that the medication reaches fatty tissue rather than muscle.

💉 Injecting the medication into muscle can increase the risk of bleeding and hematoma formation because enoxaparin is an anticoagulant.

💉 The medication should be injected slowly and steadily while the client continues holding the skinfold.

💉 After the medication is delivered, the needle should be withdrawn at the same angle and disposed of immediately in a sharps container.

“Pinch up a skin area before injection.”

💉 Pinching a fold of skin separates the subcutaneous fatty tissue from the underlying muscle.

💉 This technique helps ensure that enoxaparin is deposited in the correct tissue layer and reduces the chance of intramuscular administration.

💉 The client should gently grasp the abdominal skin between the thumb and fingers without squeezing excessively.

💉 The skinfold should remain pinched throughout the injection and should be released only after the needle has been removed.

💉 Correct skinfold technique promotes reliable medication absorption and reduces the risk of bleeding, pain, and tissue injury.


Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

5 :

Hint : 💊 Severe abdominal pain may indicate gallstones.

Correct Answers:

  • Epigastric pain


Rationale :

💊 Gemfibrozil lowers triglycerides but can increase cholesterol secretion into bile, raising the risk of gallstone formation.

💊 Persistent or severe epigastric or right upper-quadrant pain can indicate cholelithiasis or inflammation of the gallbladder.

💊 The pain may occur with nausea, vomiting, fever, jaundice, or tenderness after eating fatty foods.

💊 The client should promptly report this symptom because gallbladder complications may require laboratory testing, imaging, and discontinuation of the medication.

💊 The nurse should also teach the client to report unexplained muscle pain because gemfibrozil can rarely cause myopathy or rhabdomyolysis.


Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

6 :

Hint : 👂 Early toxicity commonly causes ringing ears.

Correct Answers:

  • Tinnitus


Rationale :

👂 Tinnitus, or ringing in the ears, is a classic early manifestation of salicylism from excessive aspirin exposure.

👂 Other early findings can include headache, dizziness, sweating, nausea, vomiting, and decreased hearing.

👂 More severe toxicity can cause tachypnea, fever, confusion, metabolic abnormalities, seizures, and coma.

👂 The nurse should hold further aspirin doses and notify the provider when salicylate toxicity is suspected.

👂 Serum salicylate levels, acid-base balance, electrolytes, respiratory status, and neurological status should be evaluated promptly.


Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

7 :

Hint : ⚠️Seizures indicate severe lithium toxicity.

Correct Answers:

  • Seizure


Rationale :

⚠️ A seizure is a severe neurological manifestation of lithium toxicity and requires immediate intervention.

⚠️ Severe toxicity can progress to confusion, coarse tremors, ataxia, coma, cardiovascular instability, and permanent neurological injury.

⚠️ The nurse should withhold lithium, protect the client from injury, maintain the airway, and notify the provider immediately.

⚠️ An urgent serum lithium level, electrolyte panel, renal function tests, and continuous neurological monitoring are indicated.

⚠️ Severe toxicity may require aggressive IV hydration or hemodialysis, particularly when renal clearance is impaired.


Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

8 :

Hint : 🚨MAO inhibitors can cause hypertensive crisis.

Correct Answers:

  • Phenelzine


Rationale :

🚨 Phenelzine is a nonselective monoamine oxidase inhibitor that can interact dangerously with levodopa.

🚨 Combining these medications can produce excessive catecholamine activity and trigger a life-threatening hypertensive crisis.

🚨 Manifestations may include severe headache, markedly elevated blood pressure, chest pain, palpitations, diaphoresis, and neurological changes.

🚨 Phenelzine generally must be discontinued for at least 14 days before levodopa therapy is initiated.

🚨 The nurse should complete a thorough medication reconciliation and immediately clarify concurrent prescriptions for these medications.


Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

9 :

Hint : 💧 Monitor for edema and heart failure.

Correct Answers:

  • Fluid retention


Rationale :

💧 Pioglitazone can cause sodium and water retention, resulting in peripheral edema and weight gain.

💧 Fluid retention can precipitate or worsen heart failure, especially in clients with existing cardiac dysfunction.

💧 The nurse should monitor daily weight, peripheral edema, lung sounds, shortness of breath, and activity tolerance.

💧 Rapid weight gain, orthopnea, crackles, or increasing dyspnea should be reported promptly to the provider.

💧 Pioglitazone is generally avoided in clients with severe or uncontrolled heart failure because of this adverse effect.


Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

10 :

Hint : 🩸Severe leukopenia risks fatal infection.

Correct Answers:

  • WBC count 2.5 / mm³ (5,000 to 10,000 / mm³)


Rationale :

🩸 A WBC count of 2.5/mm³ is critically low and suggests severe leukopenia associated with clozapine-induced neutropenia or agranulocytosis.

🩸 Clozapine can suppress bone marrow production of neutrophils, leaving the client vulnerable to rapidly developing and potentially fatal infections.

🩸 The medication should be withheld, and the provider should be notified immediately according to the clozapine monitoring protocol.

🩸 The nurse should assess for fever, sore throat, chills, mouth ulcers, malaise, and other signs of infection.

🩸 An absolute neutrophil count should be obtained because it is the primary laboratory value used to determine whether clozapine can be safely continued.


Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

Total Questions: 10

Choose Different Exam !